- Home
- ITRM vs NTIP Comparison
ITRM vs NTIP Comparison
Compare ITRM & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- NTIP
- Stock Information
- Founded
- ITRM 2015
- NTIP 1990
- Country
- ITRM Ireland
- NTIP United States
- Employees
- ITRM N/A
- NTIP N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- ITRM Health Care
- NTIP Miscellaneous
- Exchange
- ITRM Nasdaq
- NTIP Nasdaq
- Market Cap
- ITRM 40.0M
- NTIP 32.0M
- IPO Year
- ITRM 2018
- NTIP 1998
- Fundamental
- Price
- ITRM $0.68
- NTIP $1.56
- Analyst Decision
- ITRM Strong Buy
- NTIP
- Analyst Count
- ITRM 2
- NTIP 0
- Target Price
- ITRM $7.00
- NTIP N/A
- AVG Volume (30 Days)
- ITRM 723.5K
- NTIP 66.2K
- Earning Date
- ITRM 11-13-2025
- NTIP 10-23-2025
- Dividend Yield
- ITRM N/A
- NTIP 6.33%
- EPS Growth
- ITRM N/A
- NTIP N/A
- EPS
- ITRM N/A
- NTIP N/A
- Revenue
- ITRM N/A
- NTIP $150,000.00
- Revenue This Year
- ITRM N/A
- NTIP N/A
- Revenue Next Year
- ITRM $249.35
- NTIP N/A
- P/E Ratio
- ITRM N/A
- NTIP N/A
- Revenue Growth
- ITRM N/A
- NTIP N/A
- 52 Week Low
- ITRM $0.61
- NTIP $1.16
- 52 Week High
- ITRM $3.02
- NTIP $1.90
- Technical
- Relative Strength Index (RSI)
- ITRM 43.41
- NTIP 53.49
- Support Level
- ITRM $0.64
- NTIP $1.56
- Resistance Level
- ITRM $0.76
- NTIP $1.63
- Average True Range (ATR)
- ITRM 0.05
- NTIP 0.08
- MACD
- ITRM 0.01
- NTIP -0.00
- Stochastic Oscillator
- ITRM 50.69
- NTIP 32.00
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.